Up to 60% of all VTEs are hospital-associated

In the UK and worldwide, VTE is a leading cause of death and disability.
A scientific review by the World Thrombosis Day steering committee revealed that:

  • VTE can affect anyone regardless of age, gender, race or ethnicity
  • Full VTE-related costs to the NHS are difficult to extract and can go undocumented, but in the APPG for Thrombosis, annual report 2016/17, a survey of English CCGs asked what their recorded costs for VTE treatment, hospital bed days, sanctions and litigation, for 2016/17.

    Of the 22% of CCGs providing figures, the average annual cost for 2016/17 was £938,357 per CCG
    (range spread from £63,358 South Lincolnshire to £7million in the Cambridge and Peterborough CCG area)

If this figure was to be averaged across all 211 CCGs in England this would be a cost to NHS services of £197,993,327

In Scotland, a 2018 freedom of information (FOI) in 2018 evidenced that between 2008 - 2017: 75,846 people were admitted to hospital for VTE in Scotland between 2008-2017.

Over the same period, admissions with a diagnosis of VTE rose from 6,624 to 8,371.

13,961 people died from a VTE episode in Scotland between 2008-2017.

The number of patients dying of VTE in Scotland had increased by 1/3 between 2008-2017

70% of NHS Health Boards recorded more VTE-related deaths in 2017 than 2008

70% NHS Health Boards recorded increased VTE incidence in (2017 – 2008)

The cost of DVT and PE to NHS Scotland:

  • £99.9 million - the estimated cost to NHS Scotland for hospital admissions where the initial reason for admission was a DVT or a PE (2011 -2018)
  • £14.5 million - the estimated cost to NHS Scotland for hospital admissions where the initial reason for admission was a DVT or a PE (2017/18)

Ref: FOI Dec 2018 National Services Scotland (Information Services Division)

“Taking proactive steps to mandate VTE best practice locally could help to reduce this cost burden, however most health service providers appear to be unaware of what VTE is costing locally.”

VTE Risk Assessment in all English hospitals. After much campaigning, risk assessment was mandated and adverse VTE events have fallen.

In the latest NHS England data released this week the national VTE prevention programme in England shows a benefit of systematic VTE prevention driven by mandatory risk assessment.

The NHS Digital national VTE indicator shows a >20% reduction in adverse outcomes!

Avoidable events are being prevented and lives are being saved - this approach requires worldwide adoption. #PreventProtectInform

  • In Europe, there are 544,000 VTE-related deaths every year
  • In the U.S. and Europe, VTE-related events kill more people than AIDS, breast cancer, prostate cancer and motor vehicle crashes combined
  • In the UK, up to 55% of VTE cases occur during or after hospitalization, making it a leading preventable cause of hospital deat
  • Hospital-acquired thrombosis
  • Two thirds of deaths are caused by ‘hospital-acquired’ thrombosis
  • Hospital-acquired blood clots cause an estimated 25,000 preventable deaths each year
  • This accounts for 10% of all patients who die in hospital – and is : the number one cause of preventable hospital mortality

2018 Anticoagulation UK - Audit of Anticoagulation management in secondary care in England

Download report

APPTG Annual Review 2017

Download report

Venous Thromboembolism NHS cost 2016

Download Leaflet

Cost-Utility Analysis of Venous Thromboembolism Prophylaxis Strategies for People Undergoing Elective Total Hip and Total Knee Replacement Surgeries in the English National Health Service

Download Report

Deaths from VTE within 90 days of post discharge from hospital NHS Outcomes Framework Indicators – Aug 2019 release NHS Digital